Curi Bio

Curi Bio

生物技术研究

Seattle,Washington 5,804 位关注者

Human Data for Next Generation Medicines

关于我们

"Human Data for Next Generation Medicines" Curi Bio unlocks novel workflows and critical human data to inform R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for drug safety, efficacy, and potency

网站
https://www.curibio.com
所属行业
生物技术研究
规模
11-50 人
总部
Seattle,Washington
类型
私人持股
创立
2015
领域
biotechnology、tissue engineering、stem cell biology、mechanobiology、drug screening、drug development、high-throughput screening、iPSC-CM、disease modeling、cell biology、drug discovery和hiPSC

地点

  • 主要

    3000 Western Ave

    US,Washington,Seattle,98121

    获取路线

Curi Bio员工

动态

相似主页

查看职位

融资

Curi Bio 共 3 轮

上一轮

补助

US$4,400,000.00

Crunchbase 上查看更多信息